Senti Biosciences, Inc. (SNTI) - Dilution Analysis

10-Q filing | 31.0M shares outstanding

10-K filing | 31.1M shares outstanding

10-Q filing | 26.2M shares outstanding

10-Q filing | 26.1M shares outstanding

10-Q filing | 26.1M shares outstanding

S-3 filing: S-3 filing for SENTI BIOSCIENCES, INC. indicating intention to offer and sell up to $300,000,000 of common stock, preferred stock, debt securities, warrants and/or units from time to time.

S-3 filing: This S-3 filing registers for resale 52,892,500 shares of Common Stock by Selling Securityholders, including shares from the conversion of Series A Preferred Stock and issuable upon the exercise of Warrants.

10-K filing | 26.0M shares outstanding

8-K filing: Senti Biosciences, Inc. closed its subsequent closing of a private placement offering on December 31, 2024, involving the issuance and sale of 4,444 shares of Series A Preferred Stock and accompanying warrants to purchase 6,666,000 shares of Common Stock, for gross proceeds of approximately $10.0 million. ($10.0M proceeds)

8-K filing: Senti Biosciences, Inc. entered into a securities purchase agreement to issue and sell up to 21,157 shares of Series A Convertible Preferred Stock and warrants to purchase up to 31,735,500 shares of common stock in a private placement. ($47.6M proceeds)

10-Q filing | 4.6M shares outstanding

10-Q filing | 4.6M shares outstanding

8-K filing: Stock split 1-for-10 | Outstanding: 45,708,601 → 4,570,860

10-Q filing | 45.7M shares outstanding

10-K filing | 44.4M shares outstanding

10-Q filing | 44.5M shares outstanding

POS AM filing: The filing discusses the determination of the offering price for Senti Common Shares to be sold by Chardan under a prospectus, mentioning that the shares are listed on Nasdaq under the symbol 'SNTI'.

POS AM filing: This POS AM filing indicates that the price at which the Selling Securityholders may sell Senti Common Shares cannot currently be determined.

10-Q filing | 44.3M shares outstanding

8-K filing: Senti Biosciences, Inc. entered into a framework agreement with GeneFab, LLC and Valere Bio, Inc., involving the sale of assets, a sublease, a license agreement, a seller economic share agreement, a development and manufacturing services agreement, and an option agreement for GeneFab to purchase common stock. ($20.0M proceeds)

10-Q filing | 44.1M shares outstanding

10-K filing | 44.2M shares outstanding

10-Q filing | 43.4M shares outstanding

S-1 filing: S-1 filing for a shelf offering of common stock, with Chardan as underwriter. The price or prices at which the Senti Common Shares may be sold by Chardan under this prospectus cannot currently be determined.

8-K filing: Senti Biosciences entered into a Common Stock Purchase Agreement with Chardan Capital Markets for up to $50,000,000 in newly issued shares and issued 100,000 shares to Chardan as consideration for their commitment.

10-Q filing | 43.4M shares outstanding

S-1/A filing: S-1/A filing for Senti Biosciences, Inc. regarding the offering of common shares by selling securityholders. The closing price of the Senti Common Shares on July 28, 2022 was $1.86 per share.

S-1 filing: This is an S-1 filing regarding the potential sale of Senti Common Shares by Selling Securityholders. The price at which the shares may be sold cannot currently be determined. As of June 23, 2022, the closing price was $2.21 per share.

10-Q filing | 23.7M shares outstanding

10-K filing | 23.7M shares outstanding

10-Q filing | 23.7M shares outstanding

10-Q filing | 23.7M shares outstanding

10-Q filing | 23.7M shares outstanding

S-1/A filing: This is an S-1/A filing for Dynamics Special Purpose Corp registering 23,000,000 shares of Class A common stock at a proposed price of $10.00 per share, resulting in an aggregate offering price of $230,000,000.

S-1/A filing: Dynamics Special Purpose Corp. is offering 20,000,000 shares of Class A Common Stock in an initial public offering at $10.00 per share. The underwriters have a 45-day option to purchase up to 3,000,000 additional shares. Certain investors have indicated an interest in purchasing approximately $100,000,000 in shares of Class A common stock in this offering at the initial public offering price.

S-1 filing: Dynamics Special Purpose Corp. is offering 20,000,000 shares of Class A Common Stock in an initial public offering.